ORIC Pharma boosts inducement equity plan by 650k shares to 1.15M total

Oric Pharmaceuticals, Inc.

Compensation Committee approved amended 2022 Inducement Plan, adding 650,000 shares.
Total shares reserved under plan now 1,150,000, for equity grants to new employees.
Plan adopted without stockholder approval per Nasdaq inducement award rules.
Awards may only go to individuals not previously employees/directors, as hiring inducement.
Effective March 26, 2024; plan terms substantially similar to 2020 Equity Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.